Effect of fish oil on heart rate in humans - A meta-analysis of randomized controlled trials

被引:307
作者
Mozaffarian, D
Geelen, A
Brouwer, IA
Geleijnse, JM
Zock, PL
Katan, MB
机构
[1] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[5] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands
[6] Wageningen Ctr Food Sci, Wageningen, Netherlands
关键词
heart rate; fatty acids; omega-3; fish oil; meta-analysis; randomized controlled trials;
D O I
10.1161/CIRCULATIONAHA.105.556886
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - The effect of fish oil on heart rate (HR), a major risk factor for sudden death, is not well established. We calculated this effect in a meta-analysis of randomized, double-blind, placebo- controlled trials in humans. Methods and Results - Randomized trials of fish oil that evaluated HR were identified through MEDLINE (1966 through January 2005), hand-searching of references, and contact with investigators for unpublished results. Two investigators independently extracted trial data. A pooled estimate was calculated from random-effects meta-analysis. Predefined stratified meta-analyses and meta-regression were used to explore potential heterogeneity. Of 197 identified articles, 30 met inclusion criteria. Evidence for publication bias was not present. In the overall pooled estimate, fish oil decreased HR by 1.6 bpm (95% CI, 0.6 to 2.5; P = 0.002) compared with placebo. Between-trial heterogeneity was evident (Q test, P < 0.001). Fish oil reduced HR by 2.5 bpm (P < 0.001) in trials with baseline HR >= 69 bpm (median) but had little effect (0.04-bpm reduction; P = 0.56) in trials with baseline HR >= 69 bpm (P for interaction = 0.03). Fish oil reduced HR by 2.5 bpm (P < 0.001) in trials with duration >= 12 weeks but had less effect (0.7-bpm reduction; P = 0.27) in trials with duration >= 12 weeks (P for interaction = 0.07). HR reduction with fish oil intake did not significantly vary by fish oil dose (range, 0.81 to 15 g/d), type of HR measure, population age, population health, parallel versus crossover design, type of control oil, or study quality by Delphi criteria (P for interaction > 0.25 for each). Conclusions - In randomized controlled trials in humans, fish oil reduces HR, particularly in those with higher baseline HR or longer treatment duration. These findings provide firm evidence that fish oil consumption directly or indirectly affects cardiac electrophysiology in humans. Potential mechanisms such as effects on the sinus node, ventricular efficiency, or autonomic function deserve further investigation.
引用
收藏
页码:1945 / 1952
页数:8
相关论文
共 60 条
[31]   DIETARY-FAT MODULATION OF LEFT-VENTRICULAR EJECTION FRACTION IN THE MARMOSET DUE TO ENHANCED FILLING [J].
MCLENNAN, PL ;
BARNDEN, LR ;
BRIDLE, TM ;
ABEYWARDENA, MY ;
CHARNOCK, JS .
CARDIOVASCULAR RESEARCH, 1992, 26 (09) :871-877
[32]   FISH-OIL IMPROVES ARTERIAL COMPLIANCE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
MCVEIGH, GE ;
BRENNAN, GM ;
COHN, JN ;
FINKELSTEIN, SM ;
HAYES, RJ ;
JOHNSTON, GD .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (09) :1425-1429
[33]   DIETARY SUPPLEMENTATION WITH OMEGA-3 POLY-UNSATURATED FATTY-ACIDS IN PATIENTS WITH STABLE CORONARY HEART-DISEASE - EFFECTS ON INDEXES OF PLATELET AND NEUTROPHIL FUNCTION AND EXERCISE PERFORMANCE [J].
MEHTA, JL ;
LOPEZ, LM ;
LAWSON, D ;
WARGOVICH, TJ ;
WILLIAMS, LL .
AMERICAN JOURNAL OF MEDICINE, 1988, 84 (01) :45-52
[34]  
MILLS DE, 1989, J HUM HYPERTENS, V3, P111
[35]   ALTERATION OF BAROREFLEX CONTROL OF FOREARM VASCULAR-RESISTANCE BY DIETARY FATTY-ACIDS [J].
MILLS, DE ;
MAH, M ;
WARD, RP ;
MORRIS, BL ;
FLORAS, JS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (06) :R1164-R1171
[36]   Effects of eicosapentaenoic acid on blood pressure, cell membrane fatty acids, and intracellular sodium concentration in essential hypertension [J].
Miyajima, T ;
Tsujino, T ;
Saito, K ;
Yokoyama, M .
HYPERTENSION RESEARCH, 2001, 24 (05) :537-542
[37]   Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement [J].
Moher, D ;
Cook, DJ ;
Eastwood, S ;
Olkin, I ;
Rennie, D ;
Stroup, DF .
LANCET, 1999, 354 (9193) :1896-1900
[38]   Omega-3 fatty acid supplementation augments sympathetic nerve activity responses to physiological stressors in humans [J].
Monahan, KD ;
Wilson, TE ;
Ray, CA .
HYPERTENSION, 2004, 44 (05) :732-738
[39]   Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans [J].
Mori, TA ;
Bao, DQ ;
Burke, V ;
Puddey, IB ;
Beilin, LJ .
HYPERTENSION, 1999, 34 (02) :253-260
[40]   Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men [J].
Mozaffarian, D ;
Ascherio, A ;
Hu, FB ;
Stampfer, MJ ;
Willett, WC ;
Siscovick, DS ;
Rimm, EB .
CIRCULATION, 2005, 111 (02) :157-164